Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

被引:11
|
作者
Kast, Karin [1 ]
Neuhann, Teresa M. [2 ,3 ]
Goergens, Heike [4 ]
Becker, Kerstin [2 ]
Keller, Katja [1 ]
Klink, Barbara [2 ]
Aust, Daniela [5 ]
Distler, Wolfgang [1 ]
Schroeck, Evelin [2 ]
Schackert, Hans K. [4 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gynecol & Obstet, D-01062 Dresden, Germany
[2] Tech Univ Dresden, Inst Clin Genet, D-01062 Dresden, Germany
[3] Ctr Genet Med, Munich, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Surg Res, D-01062 Dresden, Germany
[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, D-01062 Dresden, Germany
来源
BMC CANCER | 2012年 / 12卷
关键词
NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR GENES; LYNCH-SYNDROME; OVARIAN-CANCER; BREAST-CANCER; BETHESDA GUIDELINES; CASE SERIES; HEREDITARY; RISKS; CARRIERS;
D O I
10.1186/1471-2407-12-531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare. Case presentation: We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years. Conclusions: Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer
    Berta Campos
    Judith Balmaña
    Josep Gardenyes
    Irene Valenzuela
    Oscar Abad
    Pere Fàbregas
    Víctor Volpini
    Orland Díez
    [J]. Breast Cancer Research and Treatment, 2013, 139 : 597 - 602
  • [42] BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
    Toh, Gaik Theng
    Kang, Peter
    Lee, Sharlene S. W.
    Lee, Daphne Shin-Chi
    Lee, Sheau Yee
    Selamat, Suhaida
    Taib, Nur Aishah Mohd
    Yoon, Sook-Yee
    Yip, Cheng Har
    Teo, Soo-Hwang
    [J]. PLOS ONE, 2008, 3 (04):
  • [43] Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
    Bonadona, Valerie
    Bonaiti, Bernard
    Olschwang, Sylviane
    Grandjouan, Sophie
    Huiart, Laetitia
    Longy, Michel
    Guimbaud, Rosine
    Buecher, Bruno
    Bignon, Yves-Jean
    Caron, Olivier
    Colas, Chrystelle
    Nogues, Catherine
    Lejeune-Dumoulin, Sophie
    Olivier-Faivre, Laurence
    Polycarpe-Osaer, Florence
    Nguyen, Tan Dat
    Desseigne, Francoise
    Saurin, Jean-Christophe
    Berthet, Pascaline
    Leroux, Dominique
    Duffour, Jacqueline
    Manouvrier, Sylvie
    Frebourg, Thierry
    Sobol, Hagay
    Lasset, Christine
    Bonaiti-Pellie, Catherine
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2304 - 2310
  • [44] Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility
    Keupp, Katharina
    Hampp, Stephanie
    Huebbel, Annette
    Maringa, Monika
    Kostezka, Sarah
    Rhiem, Kerstin
    Waha, Anke
    Wappenschmidt, Barbara
    Pujol, Roser
    Surralles, Jordi
    Schmutzler, Rita K.
    Wiesmueller, Lisa
    Hahnen, Eric
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (09):
  • [45] Frequency of germline and somatic BRCA1 mutations in ovarian cancer
    Berchuck, A
    Heron, KA
    Carney, ME
    Lancaster, JM
    Fraser, EG
    Vinson, VL
    Deffenbaugh, AM
    Miron, A
    Marks, JR
    Futreal, PA
    Frank, TS
    [J]. CLINICAL CANCER RESEARCH, 1998, 4 (10) : 2433 - 2437
  • [46] Germline BRCA1 mutations in Iranian women with breast cancer
    Ghaderi, A
    Talei, A
    Farjadian, S
    Mosalaei, A
    Doroudchi, M
    Kimura, H
    [J]. CANCER LETTERS, 2001, 165 (01) : 87 - 94
  • [47] Survival in breast cancer associated with germline mutations of BRCA1
    Verhooq, LC
    Seynaeve, C
    vanderBosch, LMC
    Brekelmans, CTM
    vanGeel, AN
    Wagner, A
    MeijersHeijboer, EJ
    vanderOuweland, A
    Devilee, P
    Klijn, JGM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 11 - 11
  • [48] Germline BRCA1 mutations increase prostate cancer risk
    Leongamornlert, D.
    Mahmud, N.
    Tymrakiewicz, M.
    Saunders, E.
    Dadaev, T.
    Castro, E.
    Goh, C.
    Govindasami, K.
    Guy, M.
    O'Brien, L.
    Sawyer, E.
    Hall, A.
    Wilkinson, R.
    Easton, D.
    Goldgar, D.
    Eeles, R.
    Kote-Jarai, Z.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (10) : 1697 - 1701
  • [49] Germline BRCA1 mutations increase prostate cancer risk
    D Leongamornlert
    N Mahmud
    M Tymrakiewicz
    E Saunders
    T Dadaev
    E Castro
    C Goh
    K Govindasami
    M Guy
    L O'Brien
    E Sawyer
    A Hall
    R Wilkinson
    D Easton
    D Goldgar
    R Eeles
    Z Kote-Jarai
    [J]. British Journal of Cancer, 2012, 106 : 1697 - 1701
  • [50] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. MODERN PATHOLOGY, 2019, 32